Application of recombinant human thrombopoietin (rhTPO) in the treatment of refractorythrombocytopenic purpura in patients with systemic lupus erythematosus

doi:10.3969/j.issn.1002-266X.2010.11.007

Home>Articles>Application of recombinant human thrombopoietin (rhTPO) in the treatment of refractorythrombocytopenic purpura in patients with systemic lupus erythematosus

DOI: 10.3969/j.issn.1002-266X.2010.11.007

Application of recombinant human thrombopoietin (rhTPO) in the treatment of refractorythrombocytopenic purpura in patients with systemic lupus erythematosus

Machine-generated Keywords：

Publication Date：2010-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：2( 19-20 )

SHANDONG MEDICAL JOURNAL

PKUISTIC

ISSN：1002-266X

Year, Vol.(Issue)：2010,50(11)